Is it possible to design rational treatments for the symptoms of Alzheimer's disease?
- 1 January 1985
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 5 (1) , 69-76
- https://doi.org/10.1002/ddr.430050107
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Treatment of Alzheimer's Disease: A Cautionary NoteNew England Journal of Medicine, 1981
- Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer typeLife Sciences, 1981
- Brain Peptides as NeurotransmittersScience, 1980
- Peptidergic neuronesNature, 1980
- DOPAMINE IN ALZHEIMER'S DISEASE AND SENILE DEMENTIAThe Lancet, 1979
- Neurotransmitter-related enzymes in senile dementia of the alzheimer typeBrain Research, 1979
- Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brainsBrain Research, 1977
- CLINICAL EFFECTS OF CHOLINE IN ALZHEIMER SENILE DEMENTIAThe Lancet, 1977
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976
- NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIESBrain, 1976